Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Alpha Interferon Following Stem Cell Transplant in Relapsed Follicular Lymphoma
NCT03069248Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jun 2000
- Primary completion
- Sep 2009
- Modality
- Cytokines & Interferons, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, interferon alfa in follicular lymphoma (FL), sponsored by Sunnybrook Health Sciences Centre. Started Jun 2000; status: completed.
02
Drugs
rituximabinterferon alfa
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03069248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069248.